Tesamorelin (5mg)
$88.00
This product is supplied for laboratory research use only and is not intended for human use. Lyophilized products may require appropriate laboratory reconstitution and handling.
Description
Tesamorelin, an analogue of growth hormone releasing hormone (GHRH), mirrors the structure of standard GHRH, enhanced by the addition of an extra trans-3-hexanoic acid group. Developed by Theratechnologies in Canada, Tesamorelin earned FDA approval in 2010 as the latest drug for managing HIV-associated lipodystrophy. Beyond its approved use, the peptide has undergone exploration regarding its potential to enhance peripheral nerve regeneration and as a potential intervention for mild cognitive impairment (MCI), which precedes dementia.
Additional Information
Benefits
Please review the complete product description and available supporting documentation for product-specific research information. This product is sold strictly for laboratory research use.
Mechanism of Action
Refer to the product description, certificate of analysis and applicable published research for product-specific information. No medical or therapeutic claims are made.
